NasdaqGS:CALM
NasdaqGS:CALMFood

Assessing Cal-Maine Foods (CALM) Valuation After Recent Share Price Weakness

Cal-Maine Foods (CALM) has recently drawn attention after a period of weaker share performance, with the stock down over the past week, month, past 3 months and year. This has prompted investors to reassess its current valuation. See our latest analysis for Cal-Maine Foods. The recent 4.4% 7 day share price decline and 15.5% 3 month share price pullback come against a 1 year total shareholder return of an 18.2% decline, but a much stronger 3 and 5 year total shareholder return. This suggests...
NYSE:RNR
NYSE:RNRInsurance

A Look At RenaissanceRe Holdings (RNR) Valuation After Recent Share Price Volatility

RenaissanceRe Holdings (NYSE:RNR) is back on investors’ radar after recent share price moves, with the stock closing at US$272.24. That puts its 1 year total return at 10.2% and its past 3 months performance at 2.0%. See our latest analysis for RenaissanceRe Holdings. Recent trading has been a bit choppy, with a 1 day share price return of 3.17% decline and a 7 day share price return of 4.09% decline. That sits against a 1 year total shareholder return of 10.2% and a 5 year total shareholder...
NasdaqCM:SKYT
NasdaqCM:SKYTSemiconductor

Why SkyWater Technology (SKYT) Is Up 21.6% After Strong Texas-Fueled Q4 Revenue Outlook

In recent days, SkyWater Technology reported strong performance from its newly acquired Texas operation and guided fourth-quarter revenue to a US$155 million–US$165 million range, ahead of its February earnings release. An important angle for investors is how this Texas facility appears to be contributing meaningfully to near-term revenue visibility and operational scale. We’ll now examine how the stronger-than-expected contribution from the Texas acquisition could influence SkyWater...
NYSE:SHW
NYSE:SHWChemicals

Assessing Sherwin-Williams (SHW) Valuation As Pricing Power And Cost Discipline Meet Key Earnings Test

Recent analyst commentary around Sherwin-Williams (SHW) has highlighted the company’s pricing power, brand strength, and cost discipline, with investors now looking to the upcoming earnings release as a key test of those themes. See our latest analysis for Sherwin-Williams. At a share price of $327.84, Sherwin-Williams has seen short term share price returns move slightly in both directions recently, while its 3 year total shareholder return of 42.72% contrasts with a slightly negative 1 year...
NasdaqGS:RUN
NasdaqGS:RUNElectrical

Sunrun’s Cash Flow And Storage Gains Might Change The Case For Investing In Sunrun (RUN)

In Q3 2025, Sunrun Inc. reported a revenue increase of 35% year over year, a 10% rise in aggregate subscriber value, strong storage adoption, and six consecutive quarters of positive cash flow, supported by US$709 million in unrestricted cash and ongoing access to capital markets. This combination of improving cash generation and storage-led unit economics has strengthened the perception of Sunrun’s business model resilience and long-term value creation potential. Next, we’ll examine how...
NYSE:KO
NYSE:KOBeverage

Coca-Cola (KO) Valuation Check After Recent Share Price Softness

Why Coca-Cola stock is on investors’ radar today Coca-Cola (KO) is back in focus after recent trading left the shares with a 1.1% one day decline and slightly lower performance over the past week and month, despite a positive past 3 months. See our latest analysis for Coca-Cola. Zooming out, Coca-Cola’s recent share price softness contrasts with a 1-year total shareholder return of 17.0% and a 5-year total shareholder return of 60.0%. This suggests longer term momentum remains positive even...
BME:ENO
BME:ENOConstruction

Is Elecnor (BME:ENO) Still Attractive After A 68% One-Year Share Price Surge?

Wondering if Elecnor at €24.85 is still good value after a strong run, or if most of the opportunity is already priced in? This article is built to help you answer that question calmly and with numbers. The stock has a 1.2% return over the last 7 days, a 16.8% decline over 30 days, a 1.6% return year to date, and a 67.7% return over 1 year, which raises fair questions about both growth potential and how risk is now being priced in. Recent coverage has focused on Elecnor's positioning within...
NYSE:MIR
NYSE:MIRElectronic

A Look At Mirion Technologies (MIR) Valuation After Its Earnings Beat And Nuclear Power Segment Strength

Mirion Technologies (MIR) has drawn fresh attention after reporting quarterly earnings per share ahead of expectations, along with strong performance in its nuclear power end market, yet the stock has retreated following the announcement. See our latest analysis for Mirion Technologies. The latest earnings news arrives after a mixed stretch in the share price, with a 3.03% 90 day share price return and a 36.25% 1 year total shareholder return suggesting long term momentum, while shorter term...
NYSE:RDN
NYSE:RDNDiversified Financial

A Look At Radian Group (RDN) Valuation As Shares Trade Near Recent Levels

Radian Group (RDN) is back on investors’ radar after recent share price moves. The stock last closed at $35.92, prompting fresh questions about how its mortgage and real estate services business is currently valued. See our latest analysis for Radian Group. While the latest move to $35.92 comes with a modest 1-day share price return of 0.19% decline and a 7-day share price return of 0.99% decline, the share price return over the last 30 and 90 days has been positive. Over the longer term,...
NasdaqGS:MLYS
NasdaqGS:MLYSBiotechs

Is JAMA-Lauded Launch-HTN And FDA Feedback Altering The Investment Case For Mineralys Therapeutics (MLYS)?

Mineralys Therapeutics recently advanced its aldosterone synthase inhibitor program as the Phase 3 Launch-HTN trial of Lorundrostat, which showed significant reductions in systolic blood pressure in treatment-resistant hypertension, was recognized in JAMA’s inaugural “Research of the Year,” and the company received FDA pre-NDA feedback supporting a planned New Drug Application submission. This recognition, combined with the prospect of additional Lorundrostat trial readouts expected in 2026,...
NasdaqCM:DCTH
NasdaqCM:DCTHMedical Equipment

Will New HEPZATO KIT Subgroup Data on Tumor Burden and Survival Change Delcath Systems' (DCTH) Narrative

Delcath Systems recently reported publication of subgroup analyses from its phase 3 FOCUS study of the HEPZATO KIT for unresectable metastatic uveal melanoma in the Journal of Cancer Research and Clinical Oncology, detailing efficacy and safety outcomes across multiple patient categories. The data highlight that patients with lower tumor burden and low or normal LDH experienced meaningfully longer progression-free and overall survival, with many responses emerging only after several...
TSE:7203
TSE:7203Auto

How Toyota’s Rising Electrified Vehicle Mix Will Impact Toyota Motor (TSE:7203) Investors

In late 2025, Toyota Motor reported a 1.9% year-on-year decline in November global sales to 965,919 vehicles, but group volumes for the first eleven months still rose 4.8% to 10.33 billion units, with Japan rebounding after earlier production stoppages. An important shift was that electrified vehicles climbed 11% to 4.56 million units over the same period, accounting for just over 47% of Toyota and Lexus global deliveries as the company invests in its own battery production while facing...
TSX:SJ
TSX:SJForestry

Could Stella-Jones’ Grid and Rail Focus Reshape Its Long-Term Capital Allocation Strategy (TSX:SJ)?

In recent months, Stella-Jones has reported ongoing strength in demand for its utility poles and railway ties, supported by recurring infrastructure and grid resiliency spending across North America. An interesting angle is the company’s continued focus on bolt-on acquisitions, which aim to deepen its presence in regions prioritizing grid hardening and rail maintenance. We’ll now examine how this sustained demand backdrop for utility poles and railway ties could influence Stella-Jones’...
ASX:AYA
ASX:AYAHealthcare Services

ASX Growth Stocks With High Insider Ownership To Watch

As the Australian market navigates a cautious start to 2026, with the ASX hovering just above the 8,700 level and mixed sector performances, investors are closely watching global events such as America's actions in Venezuela for potential impacts. In this environment of uncertainty and selective gains across sectors like materials, identifying growth companies with high insider ownership can be a strategic move, as these stocks often benefit from aligned interests between management and...
ASX:CUV
ASX:CUVBiotechs

Artrya And 2 Other High Growth Tech Stocks With Potential In Australia

As the Australian market kicks off 2026, the ASX has been relatively flat with a brief pause in the Santa Rally, while IT stocks have led declines amidst broader market uncertainties. In this environment, identifying high-growth tech stocks like Artrya and others requires careful consideration of their potential to navigate current challenges and capitalize on emerging opportunities within Australia's dynamic economic landscape.
ASX:MYG
ASX:MYGElectrical

Hidden Opportunities in Australian Stocks for January 2026

As we usher in 2026, the Australian market has been marked by a flat trading session with materials leading gains, while IT sectors lagged behind. In this landscape of cautious optimism and sector-specific movements, identifying hidden opportunities requires a keen eye for stocks that can thrive despite broader market uncertainties.
ASX:AXE
ASX:AXESemiconductor

3 ASX Penny Stocks With Market Caps Under A$700M To Consider

As the Australian market navigates a mixed start to 2026, with materials showing strength and IT lagging behind, investors are closely watching global events and their potential impacts. In such a climate, penny stocks—typically smaller or newer companies—can offer intriguing opportunities for those willing to explore beyond the established giants. Despite its somewhat dated connotation, the term "penny stock" still points to an investment area where solid financial foundations can lead to...
NasdaqGM:LUNR
NasdaqGM:LUNRAerospace & Defense

Assessing Intuitive Machines (LUNR) Valuation After Recent Share Price Strength

Event driven move in Intuitive Machines stock Intuitive Machines (LUNR) has drawn fresh attention after recent trading saw the share price close at US$17.88, with short term returns over the past week and month outpacing its past year performance. See our latest analysis for Intuitive Machines. The recent move to a US$17.88 share price comes after a sharp 30 day share price return of 59.5% and a 90 day share price return of 51.65%, set against a 1 year total shareholder return decline of...
NYSE:APO
NYSE:APODiversified Financial

Assessing Apollo Global Management’s (APO) Valuation After Mixed Recent Returns And Undervalued Fair Value Estimate

Apollo Global Management (APO) is back in focus after recent trading, with the share price last closing at $146.61. For investors, the key questions now center on returns, earnings trends, and valuation. See our latest analysis for Apollo Global Management. Recent trading has been choppy, with a 1-day share price return of 1.28% and a 30-day share price return of 6.14%. However, the 1-year total shareholder return shows a decline of 12.08%, which contrasts with a very large 3-year total...